Non–small cell lung cancer (NSCLC) is the leading cause of cancer‐related death in the
United States. With the implementation of lung cancer screening, the number and proportion …

Lung neuroendocrine tumors (LNETs) are uncommon cancers, and there is a paucity of
randomized evidence to guide practice. As a result, current guidelines from different …

Background Stereotactic ablative radiotherapy (SABR) is the standard treatment for
medically inoperable early-stage non-small-cell lung cancer (NSCLC), but regional or …

As we mark 150 years since the birth of Marie Curie, we reflect on the global advances
made in radiation oncology and the current status of radiation therapy (RT) research. Large …

Purpose: Radiotherapy with or without chemotherapy is a mainstay of treatment for locally
advanced non–small cell lung cancer (NSCLC), but no predictive markers are currently …

Until the advent of immune checkpoint inhibitors (ICIs), definitive radiotherapy (RT)
concurrently with chemotherapy was recommended for unresectable, locally advanced non …

Stereotactic body radiation therapy (SBRT) is the treatment of choice for medically
inoperable patients with early stage non-small cell lung cancer (NSCLC). A literature search …

Background Clinical decision-making for patients with stage I lung cancer is complex. It
involves multiple options [lobectomy, segmentectomy, wedge, stereotactic body …

Objectives In the present study, we aim to show the results of microwave ablation (MWA) for
medically inoperable stage I non-small cell lung cancers (NSCLCs) with long-term follow-up …

Purpose To report the feasibility of conducting a randomized study to compare the toxicity
and efficacy of stereotactic body radiation therapy (SBRT) versus stereotactic body proton …